Charles Schwab Investment Management Inc. Has $17.79 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Charles Schwab Investment Management Inc. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 6.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 191,511 shares of the medical instruments supplier's stock after purchasing an additional 11,395 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.85% of LeMaitre Vascular worth $17,789,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Summit Global Investments boosted its holdings in shares of LeMaitre Vascular by 2.4% in the 3rd quarter. Summit Global Investments now owns 6,192 shares of the medical instruments supplier's stock worth $575,000 after acquiring an additional 146 shares in the last quarter. Shaker Investments LLC OH grew its holdings in shares of LeMaitre Vascular by 1.3% during the second quarter. Shaker Investments LLC OH now owns 13,833 shares of the medical instruments supplier's stock worth $1,138,000 after purchasing an additional 175 shares during the last quarter. NBC Securities Inc. raised its holdings in shares of LeMaitre Vascular by 73.2% in the third quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier's stock valued at $40,000 after buying an additional 183 shares during the last quarter. GAMMA Investing LLC lifted its position in LeMaitre Vascular by 34.3% during the 3rd quarter. GAMMA Investing LLC now owns 736 shares of the medical instruments supplier's stock worth $68,000 after buying an additional 188 shares in the last quarter. Finally, nVerses Capital LLC increased its position in LeMaitre Vascular by 33.3% in the 2nd quarter. nVerses Capital LLC now owns 800 shares of the medical instruments supplier's stock valued at $66,000 after acquiring an additional 200 shares in the last quarter. 84.64% of the stock is owned by institutional investors and hedge funds.

LeMaitre Vascular Price Performance

LMAT traded down $1.36 during mid-day trading on Friday, hitting $101.12. The stock had a trading volume of 117,237 shares, compared to its average volume of 107,449. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of 55.26, a price-to-earnings-growth ratio of 2.57 and a beta of 0.93. The stock's fifty day simple moving average is $96.82 and its 200-day simple moving average is $88.91. LeMaitre Vascular, Inc. has a 1-year low of $52.72 and a 1-year high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its earnings results on Thursday, October 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.05. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The company had revenue of $54.82 million for the quarter, compared to analyst estimates of $53.50 million. During the same period in the prior year, the firm posted $0.33 EPS. LeMaitre Vascular's quarterly revenue was up 15.6% on a year-over-year basis. As a group, research analysts expect that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 5th. Investors of record on Thursday, November 21st were paid a $0.16 dividend. The ex-dividend date of this dividend was Thursday, November 21st. This represents a $0.64 dividend on an annualized basis and a yield of 0.63%. LeMaitre Vascular's dividend payout ratio (DPR) is 34.97%.

Insider Buying and Selling at LeMaitre Vascular

In other LeMaitre Vascular news, Director Bridget A. Ross sold 3,750 shares of the firm's stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.47, for a total value of $380,512.50. Following the sale, the director now owns 2,278 shares in the company, valued at $231,148.66. This trade represents a 62.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 10.79% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. JMP Securities raised their price target on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the company a "market outperform" rating in a report on Tuesday, August 20th. Barrington Research boosted their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. Cantor Fitzgerald initiated coverage on LeMaitre Vascular in a report on Tuesday, October 15th. They issued a "neutral" rating and a $96.00 price target on the stock. StockNews.com upgraded shares of LeMaitre Vascular from a "hold" rating to a "buy" rating in a research report on Thursday. Finally, Oppenheimer reiterated an "outperform" rating and set a $93.00 price target (up previously from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $94.57.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.